NM_000179.3(MSH6):c.182C>T (p.Ala61Val) AND Hereditary nonpolyposis colorectal neoplasms

Clinical significance:Uncertain significance (Last evaluated: Jun 24, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_000179.3(MSH6):c.182C>T (p.Ala61Val)]

NM_000179.3(MSH6):c.182C>T (p.Ala61Val)

MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.182C>T (p.Ala61Val)
  • NC_000002.12:g.47783415C>T
  • NG_007111.1:g.5269C>T
  • NM_000179.3:c.182C>TMANE SELECT
  • NM_001281492.2:c.182C>T
  • NM_001281493.2:c.-555C>T
  • NP_000170.1:p.Ala61Val
  • NP_000170.1:p.Ala61Val
  • NP_001268421.1:p.Ala61Val
  • LRG_219t1:c.182C>T
  • LRG_219:g.5269C>T
  • LRG_219p1:p.Ala61Val
  • NC_000002.11:g.48010554C>T
  • NM_000179.2:c.182C>T
Protein change:
dbSNP: rs572336612
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_001281493.2:c.-555C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000179.3:c.182C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.182C>T - missense variant - [Sequence Ontology: SO:0001583]


Hereditary nonpolyposis colorectal neoplasms
MedGen: C0009405; Orphanet: 443090

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV000931355Invitaecriteria provided, single submitter
Uncertain significance
(Jun 24, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

Details of each submission

From Invitae, SCV000931355.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)


This sequence change replaces alanine with valine at codon 61 of the MSH6 protein (p.Ala61Val). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs572336612, ExAC 0.08%). This variant has not been reported in the literature in individuals with MSH6-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 4, 2021

Support Center